XML 44 R33.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-based Payments and Director Fees (Tables)
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of management fees and director fees
The following table sets forth the Company’s stock-based management fees and independent director fees ($ in thousands except share amounts):

Stock-based Management Fees and Director Fees

For the year ended December 31,
201920182017
Number
of shares
Amount of
expense
recognized(1)
Number
of shares
Amount of
expense
recognized(1)
Number
of shares
Amount of
expense
recognized(1)
Management fees184,681  $2,600  200,405  $2,813  150,652  $2,335  
Independent director fees10,948  158  9,628  150  9,708  150  
Total195,629  $2,758  210,033  $2,963  160,360  $2,485  

(1)All management fees and independent director fees are fully expensed in the period in which the underlying expense is incurred.
Schedule of activity in restricted stock
The following table sets forth the activity in the Company’s restricted stock plans ($ in thousands, except per share amounts):

Total GrantsActivity Non-vested shares at December 31, 2019Fully-vested shares at December 31, 2019
Year ended December 31, 2019Total
shares
granted
Total
expected
cost of
grant
Shares
granted
during
the year
Grant
expense
recognized
for the
year
SharesPer share
grant fair
value
SharesPer share grant date fair value
Directors’ Grants 2018(1)
12,000  $162  —  $—  —  $13.48  12,000  $13.48  
Employee and Service Provider Grant 2016(2,6)
144,667  1,953  —  367  —  13.50  144,667  13.50  
Employee and Service Provider Grant 2017(3,7)
38,667  539  —  170  12,667  13.95  26,000  13.95  
Employee and Service Provider Grant 2018(4,8)
34,000  462  —  149  22,667  13.58  11,333  13.58  
Employee and Service Provider Grant 2019(5)
79,000  1,101  79,000  153  79,000  13.94  —  —  
Totals308,334  $4,217  79,000  $839  114,334  $13.87  194,000  $13.56  

(1)Half of the 12,000 shares granted vest immediately while the remaining shares vest ratably over a one-year from grant date. Grant is fully vested at December 31, 2019.
(2)Vesting is ratable over three-year period from grant date. Grant is fully vested at December 31, 2019.
(3)Vesting is ratable over three-year period from grant date. Weighted average remaining life of grant at December 31, 2019 is 0.6 years.
(4)Vesting is ratable over three-year period from grant date. Weighted average remaining life of grant at December 31, 2019 is 1.6 years.
(5)Vesting is ratable over three-year period from grant date. Weighted average remaining life of grant at December 31, 2019 is 2.6 years.
(6)Total is shown net of 2017 forfeitures of 4,000 shares, 2018 forfeitures of 2,666 shares and 2019 forfeitures of 1,667 shares.
(7)Total is shown net of 2019 forfeitures of 333 shares.
(8)Total is shown net of 2019 forfeitures of 2,500 shares.

Total GrantsActivity Non-vested shares at December 31, 2018Fully-vested shares at December 31, 2018
Year ended December 31, 2018Total
shares
granted
Total
expected
cost of
grant
Shares
granted
during
the year
Grant
expense
recognized
for the
year
SharesPer share
grant fair
value
SharesPer share grant date fair value
Directors’ Grants(1)
12,000  $162  12,000  $148  6,000  $13.48  6,000  $13.48  
Employee and Service Provider Grant 2016(2,5)
146,334  1,976  —  629  47,889  13.50  98,445  13.50  
Employee and Service Provider Grant 2017(3)
39,000  544  —  180  26,000  13.95  13,000  13.95  
Employee and Service Provider Grant 2018(4)
36,500  496  36,500  69  36,500  13.58  —  —  
Totals233,834  $3,178  48,500  $1,026  116,389  $13.62  117,445  $13.55  
(1)Half of the 12,000 shares granted vest immediately while the remaining shares vest ratably over one-year from grant date. Weighted average remaining life of unvested shares at December 31, 2018 is 0.2 years.
(2)Vesting is ratable over three-year period from grant date. Weighted average remaining life of grant at December 31, 2018 is 0.6 years.
(3)Vesting is ratable over three-year period from grant date. Weighted average remaining life of grant at December 31, 2018 is 1.6 years.
(4)Vesting is ratable over three-year period from grant date. Weighted average remaining life of grant at December 31, 2018 is 2.6 years.
(5) Total is shown net of 2017 forfeitures of 4,000 shares and 2018 forfeitures of 2,666 shares.

Total GrantsActivity Non-vested shares at December 31, 2017Fully-vested shares at December 31, 2017
Year ended December 31, 2017Total
shares
granted
Total
expected
cost of
grant
Shares
granted
during
the year
Grant
expense
recognized
for the
year
SharesPer share
grant fair
value
SharesWeighted
average
grant
date fair
value
Directors’ Grants(1)
10,000  $146  —  $14  —  $—  10,000  $14.61  
Employee and Service Provider Grant 2016(2,4)
149,000  2,027  —  675  99,333  13.50  49,667  13.50  
Employee and Service Provider Grant 2017(3)
39,000  542  39,000  76  39,000  13.95  —  —  
Totals198,000  $2,715  39,000  $765  138,333  $13.83  59,667  $13.69  

(1)Vesting period is one-year from grant date. Grant is fully vested at December 31, 2017.
(2)Vesting is ratable over three-year period from grant date. Weighted average remaining life of grant at December 31, 2017 is 1.6 years​
(3)Vesting is ratable over three-year period from grant date. Weighted average remaining life of grant at December 31, 2017 is 2.6 years.
(4)Total is shown net of 2017 forfeitures of 4,000 shares.